Cochrane Abstracts
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short‐term Treatment With Proton Pump Inhibitors, H2‐receptor Antagonists and Prokinetics for Gastro‐oesophageal Reflux Disease‐like Symptoms and Endoscopy Negative Reflux Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short‐term_treatment_with_proton_pump_inhibitors__H2‐receptor_antagonists_and_prokinetics_for_gastro‐oesophageal_reflux_disease‐like_symptoms_and_endoscopy_negative_reflux_disease.
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short‐term_treatment_with_proton_pump_inhibitors__H2‐receptor_antagonists_and_prokinetics_for_gastro‐oesophageal_reflux_disease‐like_symptoms_and_endoscopy_negative_reflux_disease. Accessed February 10, 2026.
Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short‐term_treatment_with_proton_pump_inhibitors__H2‐receptor_antagonists_and_prokinetics_for_gastro‐oesophageal_reflux_disease‐like_symptoms_and_endoscopy_negative_reflux_disease
Short‐term Treatment With Proton Pump Inhibitors, H2‐receptor Antagonists and Prokinetics for Gastro‐oesophageal Reflux Disease‐like Symptoms and Endoscopy Negative Reflux Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short‐term_treatment_with_proton_pump_inhibitors__H2‐receptor_antagonists_and_prokinetics_for_gastro‐oesophageal_reflux_disease‐like_symptoms_and_endoscopy_negative_reflux_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease
ID - 435254
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435254/all/Short‐term_treatment_with_proton_pump_inhibitors__H2‐receptor_antagonists_and_prokinetics_for_gastro‐oesophageal_reflux_disease‐like_symptoms_and_endoscopy_negative_reflux_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
